SAMAREC
| Name of member | Field of interest | Designations for REC |
|---|---|---|
| Dr N Naidoo | Clinical Pathologist | Chairperson, Medical Professional, Indian, Male |
| Ms T Coetzee | Health Research Ethicist | Vice Chairperson, Research Ethics Expert, White, Female |
| Dr C Khoza | Public Health Clinician | Medical Professional, Black, Male, |
| Dr Z Mafika | Haematopathologist | Medical Professional, Black, Male |
| Ms N Madolo | Quantitative Research | Experience in Quantitative Research methodologies, Black, Female |
| Mr R Masemola | Legal Advisor | Legal Representative, Medico Legal Advisor, Black, Male |
| Ms M Ratsiu | Epidemiology & Biostatistics | Biostatistician, Black, Female |
| Ms K Ledibane | Psychologist | Counsellor, Community Representative, Black, Female |
| Dr L Pillay | Sport Medicine | Medical Professional, Indian, Male |
| Dr S Nyamathe | Public Health Clinician | SAE Officer, Medical Professional, Qualitative Research, Black, Female |
| Ms S Abdurahman | Legal Advisor | Legal Representative, Medico-Legal Advisor, Coloured, Female |
| Prof NJ Mekwa | Professor Emerita | Layperson Representative, Black, Female |
The South African Medical Association Research Ethics Committee (SAMAREC) was established by the SA Medical Association (SAMA) in 1992 to evaluate the ethics of research protocols developed for clinical trials to be conducted in the private healthcare sector.
The main responsibility of SAMAREC is to ensure the protection and respect of the rights, safety and well being of participants involved in clinical trials and to provide public assurance of that protection by reviewing, approving and providing comment on clinical trial protocols, the suitability of investigator(s), facilities, methods and procedures used to obtain informed consent.
Standard Operating Procedures (SOP) and Guidelines
SAMAREC SOPs
- SAMAREC Auditing Guidelines, v2, Oct 2023
- SAMAREC Biological Materials, Databases, Registries and Repositories, V1, Oct 2023
- SAMAREC Continuing Review Annual Renewal Recertification, V1, Oct 2023
- SAMAREC Data Management, V1, Nov 2024
- SAMAREC Decisional Analysis, V1, Oct 2023
- SAMAREC Informed Consent, V2, Jul 2025
- SAMAREC Non Clinical Research Guidelines, V4, Jul 2025
- SAMAREC Rapid Review Guidelines, V1, Oct 2023
- SAMAREC Risk Assessment, V1, Oct 2023
- SAMAREC Site Staff, V2, Jul 2025
- SAMAREC Standard Operating Procedures, V11, Jul 2025
- SAMAREC Standard Operating Procedure Annexures, V5, Jul 2025
- SAMAREC Terms of Reference, V4, Nov 2024
- SAMAREC Whistle Blower, V2, Jul 2025
- SAMAREC Meeting Dates 2024/2025
SAMAREC Templates
- SAMAREC App Form, V4
- SAMAREC Active Audit Form, V2, Oct 2023
- SAMAREC Non Clinical Research App Form, V2
- SAMAREC Non Clinical Research PID Pro Forma, V1, Jun 2024
- SAMAREC Non Clinical Research CV, V1, Jun 2024
- SAMAREC Non Clinical Research Sup Declaration, V1, Jun 2024
- SAMAREC Non Clinical Data Management Template, V1, Aug 2024
- SAMAREC Passive Audit Report Form, V1, Oct 2023
- SAMAREC Progress Report Template, V1, May 2024
- SAMAREC SAE Report Form, V1, Oct 2023
- SAMAREC Site Delegation Log Template, V1, Oct 2023
- SAMAREC Study Closure Form, V1, Apr 2024
Additional Guideline
SAMAREC Whistle Blower
The SAMA Research Ethics Committee (SAMAREC) calls on all study staff or participants to ask questions about your participation in any of our approved studies. Please report any problems or concerns you may have about any study. You may contact the Research Ethics Committee (REC) anonymously on this page
SAMAREC is a REC whose committee members provide Research Ethics Committee services for participants and study staff involved in research studies in the Private Sector in South Africa.